ERDERA Launches the 2025 Joint Transnational Call for Proposals on Rare Disease Therapies 

ERDERA Launches the 2025 Joint Transnational Call for Proposals on Rare Disease Therapies

The European Rare Diseases Research Alliance (ERDERA) is delighted to announce the official launch of its 2025 Joint Transnational Call (JTC) for Proposals as of today, 10 December 2024. This eagerly anticipated call invites research teams across Europe and internationally to collaborate on cutting-edge projects aimed at “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.” 

See all the details of the official call here.  

Application Timeline 

The JTC 2025 will follow a two-stage submission process: 

  • 13 February 2025: Pre-proposal submission deadline. 
  • 9 July 2025: Full proposals submission deadline. Funding decisions are expected by December 2025. 

Interested applicants can join an informational webinar on 17 December 2024, providing valuable guidance on preparing submissions. 

For more information, contact the Joint Call Secretariat at SelteneErkrankungen@dlr.de or reach out to the relevant national contact point. 

Stay informed with the latest updates from ERDERA by subscribing to our newsletter and following us on social media. 

News & Updates

You might also be interested in

Amsterdam and online, convening clinicians, scientists and advocates to share progress and the power of patient led policy to improve diagnosis and care.
Sharing patient‑centred methods, early diagnostics, and data‑driven trial innovation to accelerate rare disease research across Europe.
Enhancing active patient involvement and data models across rare disease research.
This information webinar on the 2026 Joint Transnational Call for Proposals is scheduled for 16 December 2025, 15:00–17:00 CET, focusing on resolving unsolved rare genetic and non‑genetic diseases through variant validation and new technological approaches.